Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian T Helfand

Showing results (41-50 of 245) with videos related to

Pageof 25
Sort By:
The Urologic Clinics of North America|November 28, 2009
Established medical therapy for benign prostatic hyperplasiaGregory B Auffenberg, Brian T Helfand, Kevin T McVary
BJU International|July 2, 2010
Number of prostate cancer risk alleles may identify possibly 'insignificant' diseaseBrian T Helfand, Stacy Loeb, Donghui Kan, et al.
The Prostate|September 23, 2010
Prostate cancer risk alleles significantly improve disease detection and are associated with aggressive features in patients with a "normal" prostate specific antigen and digital rectal examinationBrian T Helfand, Donghui Kan, Parth Modi, et al.
Journal of Cell Science|April 25, 2003
Rapid transport of neural intermediate filament proteinBrian T Helfand, Patty Loomis, Miri Yoon, et al.
The Journal of Cell Biology|May 30, 2002
A requirement for cytoplasmic dynein and dynactin in intermediate filament network assembly and organizationBrian T Helfand, Atsushi Mikami, Richard B Vallee, et al.
Urology|March 11, 2008
Complications of open radical retropubic prostatectomy in potential candidates for active monitoringStacy Loeb, Kimberly A Roehl, Brian T Helfand, et al.
Urology|March 30, 2010
Determining the utility of recalled lower urinary tract symptomsBrian T Helfand, Angela Fought, Ankur M Manvar, et al.
Urology|February 25, 2015
Family history of prostate cancer in men being followed by active surveillance does not increase risk of being diagnosed with high-grade diseaseChristina G Selkirk, Chi-Hsiung Wang, Brittany Lapin, et al.
Prostate Cancer and Prostatic Diseases|August 17, 2019
Inherited risk assessment of prostate cancer: it takes three to do it rightJianfeng Xu, Craig V Labbate, William B Isaacs, et al.
Journal of Medicinal Chemistry|September 19, 2003
A specific mechanism of nonspecific inhibitionSusan L McGovern, Brian T Helfand, Brian Feng, et al.
Pageof 25

Showing results (41-50 of 245) with videos related to

Sort By:
Pageof 25
The Urologic Clinics of North America|November 28, 2009
Established medical therapy for benign prostatic hyperplasiaGregory B Auffenberg, Brian T Helfand, Kevin T McVary
BJU International|July 2, 2010
Number of prostate cancer risk alleles may identify possibly 'insignificant' diseaseBrian T Helfand, Stacy Loeb, Donghui Kan, et al.
The Prostate|September 23, 2010
Prostate cancer risk alleles significantly improve disease detection and are associated with aggressive features in patients with a "normal" prostate specific antigen and digital rectal examinationBrian T Helfand, Donghui Kan, Parth Modi, et al.
Journal of Cell Science|April 25, 2003
Rapid transport of neural intermediate filament proteinBrian T Helfand, Patty Loomis, Miri Yoon, et al.
The Journal of Cell Biology|May 30, 2002
A requirement for cytoplasmic dynein and dynactin in intermediate filament network assembly and organizationBrian T Helfand, Atsushi Mikami, Richard B Vallee, et al.
Urology|March 11, 2008
Complications of open radical retropubic prostatectomy in potential candidates for active monitoringStacy Loeb, Kimberly A Roehl, Brian T Helfand, et al.
Urology|March 30, 2010
Determining the utility of recalled lower urinary tract symptomsBrian T Helfand, Angela Fought, Ankur M Manvar, et al.
Urology|February 25, 2015
Family history of prostate cancer in men being followed by active surveillance does not increase risk of being diagnosed with high-grade diseaseChristina G Selkirk, Chi-Hsiung Wang, Brittany Lapin, et al.
Prostate Cancer and Prostatic Diseases|August 17, 2019
Inherited risk assessment of prostate cancer: it takes three to do it rightJianfeng Xu, Craig V Labbate, William B Isaacs, et al.
Journal of Medicinal Chemistry|September 19, 2003
A specific mechanism of nonspecific inhibitionSusan L McGovern, Brian T Helfand, Brian Feng, et al.
Pageof 25